These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 466651
21. Nitrogen utilization in mice bearing Ehrlich ascites tumor treated with Acinetobacter glutaminase-asparaginase. Kien CL, Holcenberg JS. Cancer Res; 1981 Jun; 41(6):2051-5. PubMed ID: 7237413 [Abstract] [Full Text] [Related]
22. Cancer therapy with chemically modified enzymes. II. The therapeutic effectiveness of arginase, and arginase modified by the covalent attachment of polyethylene glycol, on the taper liver tumor and the L5178Y murine leukemia. Savoca KV, Davis FF, van Es T, McCoy JR, Palczuk NC. Cancer Biochem Biophys; 1984 Sep; 7(3):261-8. PubMed ID: 6488153 [Abstract] [Full Text] [Related]
23. Phase I study of succinylated acinetobacter L-glutaminase-L-asparaginase. Holcenberg JS, Camitta BM, Borella LD, Ring BJ. Cancer Treat Rep; 1979 Jun; 63(6):1025-30. PubMed ID: 380800 [No Abstract] [Full Text] [Related]
29. Polyethylene glycol-L-asparaginase and L-asparaginase studies in rabbits. Ho DH, Wang CY, Lin JR, Brown N, Newman RA, Krakoff IH. Drug Metab Dispos; 1988 Jun; 16(1):27-9. PubMed ID: 2894951 [Abstract] [Full Text] [Related]
30. Prevention of methotrexate cytotoxicity by asparaginase inhibition of methotrexate polyglutamate formation. Jolivet J, Cole DE, Holcenberg JS, Poplack DG. Cancer Res; 1985 Jan; 45(1):217-20. PubMed ID: 2578094 [Abstract] [Full Text] [Related]
31. Enhancement of antitumor activity of glutamine antagonists 6-diazo-5-oxo-L-norleucine and acivicin in cell culture by glutaminase-asparaginase. Rosenfeld H, Roberts J. Cancer Res; 1981 Apr; 41(4):1324-8. PubMed ID: 7214322 [Abstract] [Full Text] [Related]
32. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo. Guo QL, Wu MS, Chen Z. Acta Pharmacol Sin; 2002 Oct; 23(10):946-51. PubMed ID: 12370101 [Abstract] [Full Text] [Related]
33. Development of medium for enhanced production of glutaminase-free L-asparaginase from Pectobacterium carotovorum MTCC 1428. Kumar S, Pakshirajan K, Venkata Dasu V. Appl Microbiol Biotechnol; 2009 Sep; 84(3):477-86. PubMed ID: 19352649 [Abstract] [Full Text] [Related]
34. Immunological effects of native and polyethylene glycol-modified asparaginases from Vibrio succinogenes and Escherichia coli in normal and tumour-bearing mice. Bendich A, Kafkewitz D, Abuchowski A, Davis FF. Clin Exp Immunol; 1982 Apr; 48(1):273-8. PubMed ID: 7044632 [Abstract] [Full Text] [Related]
36. Role of amino acid depletion in combined treatment of neoplastic cells with methotrexate and L-asparaginase. Chlopkiewicz B, Koziorowska J. Cancer Res; 1975 Jun; 35(6):1524-9. PubMed ID: 805660 [Abstract] [Full Text] [Related]
37. Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial? Hong RL, Huang CJ, Tseng YL, Pang VF, Chen ST, Liu JJ, Chang FH. Clin Cancer Res; 1999 Nov; 5(11):3645-52. PubMed ID: 10589782 [Abstract] [Full Text] [Related]
39. L-cyst(e)ine requirements of malignant cells and progress toward depletion therapy. Uren JR, Lazarus H. Cancer Treat Rep; 1979 Jun; 63(6):1073-9. PubMed ID: 466647 [Abstract] [Full Text] [Related]
40. Polyethylene glycol conjugation of recombinant methioninase for cancer therapy. Tan Y, Sun X, Xu M, An Z, Tan X, Han Q, Miljkovic DA, Yang M, Hoffman RM. Protein Expr Purif; 1998 Feb; 12(1):45-52. PubMed ID: 9473456 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]